1-2 of 2
Bernhard Wörmann, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DNMT3A Mutations Associate with Shorter Survival and Modulate the Prognostic Impact of Mutated NPM1: an Analysis Based on Comprehensive Mutational Screening of 660 AML Patients Treated on German AML Cooperative Group (AMLCG) Trials

Klaus H. Metzeler, MD, Tobias Herold, MD, Maja Rothenberg-Thurley, PhD, Susanne Amler, Cristina Sauerland, Stephanie Schneider, PhD, Nikola P Konstandin, PhD, Annika Maria Dufour, PhD, Kathrin Bräundl, Bianka Ksienzyk, Evelyn Zellmeier, Luise Hartmann, MSc, Philipp A. Greif, MD, Michael Fiegl, MD, Marion S. Subklewe, MD, Stefan K. Bohlander, MD, Utz Krug, MD, Wolfgang E Berdel, MD, Bernhard Wörmann, MD, Thomas Büchner, MD, Andreas Faldum, PhD, Wolfgang Hiddemann, MD, Jan Braess, MD, Karsten Spiekermann, MD
Journal: Blood
Blood (2015) 126 (23): 3815.
https://doi.org/10.1182/blood.V126.23.3815.3815
Published: 2015
Journal Articles

High Antileukemic Efficacy and Shortened Neutropenia of Dose-Dense Induction (Sequential-HAM Followed by Pegfilgrastim) in Primary Acute Myeloid Leukemia - Results of a Pilot Study of the German AML-CG.

Jan Braess, MD, PhD, Karsten Spiekermann, MD, PhD, Christian Buske, MD, PhD, Peter Staib, MD, PhD, Wolf-Dieter Ludwig, MD, PhD, Andreas Gruneisen, MD, Christa Sauerland, PhD, Michael Unterhalt, MD, PhD, Michael Fiegl, MD, Bernhard Wormann, MD, PhD, Wolfgang Kern, MD, PhD, Achim Heinicke, PhD, Wolfgang Berdel, MD, PhD, Thomas Büchner, MD, PhD, Wolfgang Hiddemann, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 295.
https://doi.org/10.1182/blood.V110.11.295.295
Published: 2007